China is transitioning into a new longevity era, yet a significant gap persists between total life expectancy and healthy living. With the average lifespan reaching 79 years but healthy life expectancy stalling under 69, Ping An Good Doctor CEO He Mingke argues that current passive healthcare models are no longer sufficient.
Kristen Nunery, CEO of tech firm illumend, warns that businesses relying on manual spreadsheets and email threads to track Certificates of Insurance are inviting significant operational risk. While these workarounds appear functional, they often mask inconsistent approval processes and a lack of documented reasoning behind vital third-party risk decisions.
NASA has expanded its contract with PlanetiQ to include high-resolution polarimetric GNSS radio occultation data under the Commercial Smallsat Data Acquisition program. This addition provides government researchers with specialized atmospheric observations designed to sharpen the detection of precipitation, storm intensity, and complex cloud structures through advanced signal analysis.
After 15 years at his previous firm, veteran financial advisor Joe Garissi has moved to Inspire Advisors, citing a need for greater alignment between his professional practice and his Christian convictions. His transition highlights a mounting tension for advisors navigating firm policies that limit faith-based client communications.
Soccer fans looking to spice up their tournament watch parties might find their ultimate centerpiece on Instagram this summer. Farm Rich is hosting a giveaway for a custom-built foosball table, where the traditional plastic athletes have been swapped out for miniature, game-day-ready mozzarella sticks.
Under the roof of Munich’s Messe München, Risen Energy has transformed its booth into a testing ground for integrated energy independence, showcasing a product matrix that spans from residential battery systems to high-efficiency modules designed for both terrestrial utility-scale projects and Low Earth Orbit satellite applications.
With Chinese life expectancy reaching 79 years while healthy life expectancy lags at 69, the nation faces a ten-year health deficit. At the 2026 Summer Davos in Dalian, Ping An Good Doctor CEO He Mingke argued that shifting from reactive treatment to proactive longevity management is now a national imperative.
As the Middle East cements its role as a global technology hub, Bybit has introduced dedicated AI Subaccounts to mitigate the risks associated with automated trading. The feature provides an isolated, secure environment for AI agents, preventing unauthorized access to primary asset portfolios while supporting regional digital asset growth.
At the 17th Summer Davos in Dalian, Yidu Tech founder Gong Yingying argued that the path to faster drug accessibility lies in building a robust evidence layer. By transforming fragmented clinical data into structured, verifiable insights, the company aims to bridge the gap between AI development and real-world patient outcomes.
Addressing shareholders in Gothenburg on June 23, Minesto CEO Dr. Martin Edlund detailed the company’s current trajectory and strategic goals during the 2026 Annual General Meeting. The full presentation, which covers operational progress and future technical milestones, has been made available for public review via the company’s official YouTube channel.
In the shadow of snow-capped peaks, the Nyang River has become the center of a sweeping ecological transformation. By blending local traditional stewardship with systemic government oversight, residents of Nyingchi are turning the "tears of a goddess" into a model for sustainable development across the Qinghai-Xizang Plateau.
At the fourth China International Supply Chain Expo in Beijing, Yili launched a digital comic series, "The Full Chain Alliance: Enora's Super Adventure." Utilizing generative artificial intelligence, the dairy giant visualizes its complex "grass to glass" production process, aiming to demystify industrial operations for a mass audience.
Juniper Research has named Comviva an Established Leader in its 2025–2030 digital wallet competitor leaderboard, citing the firm's influence on financial inclusion and its technical versatility. The ranking highlights the company’s ability to scale complex financial ecosystems across emerging markets through its flagship mobiquity® Pay platform.
China’s National Medical Products Administration has authorized Satri-cel, the world’s inaugural CAR-T cell treatment for solid tumors. This milestone targets Claudin18.2-positive, HER2-negative advanced gastric and gastroesophageal junction adenocarcinoma, offering a new clinical pathway for patients who have exhausted at least two previous lines of standard therapeutic intervention.
A landmark regulatory approval in China has cleared the way for Satri-cel, the first CAR-T cell therapy designed to combat solid tumors. The treatment targets Claudin18.2-positive, HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma, providing a vital option for patients who have exhausted at least two previous lines of standard therapy.
Professional fundraiser Colossal generated over $100 million in charitable support during 2025, leveraging a series of online competitions to fund causes ranging from pediatric cancer research and ocean conservation to food insecurity. The organization channeled these contributions through DTCare, a 501(c)(3) public charity, to support various nonprofit partners.
London-based MoEngage has acquired San Francisco AI startup Aampe, aiming to replace traditional segment-based marketing with autonomous, per-user agents. By integrating Aampe’s reinforcement learning engine, the platform shifts from static campaigns to a model where individual AI agents continuously optimize content, timing, and channel for every customer in real time.
London-based MoEngage has acquired San Francisco startup Aampe to integrate autonomous AI agents into its customer engagement platform. By deploying one dedicated agent for every individual user rather than relying on broad segments, the company aims to move beyond traditional marketing automation toward fully personalized, real-time decisioning.
At Intersolar Europe 2026, Trina Storage unveiled the Elementa + Electra, a 13.8MVA/25MWh integrated solution designed to streamline utility-scale energy storage. The system merges advanced battery storage with upgraded AC power conversion, aiming to reduce site complexity and accelerate project commissioning for large-scale renewable applications.
At Intersolar Europe 2026, Sungrow unveiled the SG125CX-P3, a 125kW string inverter engineered for commercial and industrial solar installations. The new hardware integrates active protection architecture with high-efficiency power conversion, aiming to mitigate fire risks and equipment downtime in complex, large-scale energy environments.
At Intersolar Europe 2026, Tongwei Solar secured the Global Strategic Partner Award from TÜV Rheinland, cementing its position as a dominant force in the photovoltaic sector. The accolade recognizes the company’s sustained excellence in manufacturing, technological innovation, and its ability to maintain consistent product quality on a global scale.
Istanbul-based technology firm Odine has secured a strategic partnership with Silicon Valley giant Supermicro to accelerate the deployment of high-performance AI infrastructure across Türkiye. The collaboration focuses on building sovereign AI factories and GPU-powered data centers to meet the country's surging demand for real-time computing and data processing.
Nearly 70% of senior executives now fear a disorderly climate transition, citing policy volatility and geopolitical instability as primary threats to operations. Despite these mounting economic risks, the vast majority of firms remain committed to green investment, viewing sustainable practices as a core pillar of long-term competitiveness.
As computing demands outpace grid capacity, Envision unveiled a suite of integrated power solutions at Intersolar Europe 2026. The new portfolio, headlined by AI-specific power architecture and long-duration storage, aims to transform intermittent renewable energy into a stable, dispatchable resource for data centers and industrial infrastructure.
Nearly two-thirds of organizations now believe a major cyber attack could jeopardize their very survival, marking a shift from fringe concern to mainstream consensus. Data from the 2026 Health Check survey highlights that digital incursions have officially surpassed hardware failure as the primary driver of operational downtime.
Anil Agarwal’s Vedanta Group has officially debuted four new independent companies on the Bombay Stock Exchange and National Stock Exchange. The demerger transforms the industrial giant into five distinct, specialized entities, marking a pivot toward focused management and targeted capital allocation for India’s energy and infrastructure sectors.
Four new Vedanta subsidiaries hit the boards of the Bombay and National Stock Exchanges today, capping a massive corporate restructuring. Chairman Anil Agarwal says the move transforms the group into a collection of specialized firms, each with its own management team and capital allocation strategy tailored for India’s industrial growth.
Lundbeck is set to present fresh clinical findings on its migraine portfolio at the European Academy of Neurology Congress in Geneva, taking place June 27–30. The company will showcase data for its established therapy, Vyepti, alongside primary results from the Phase IIb PROCEED trial for the investigational candidate, bocunebart.
A top-tier European telecommunications provider has signed a multi-year agreement to deploy Mycom’s PrOptima performance management software. The deal aims to streamline network operations for a subscriber base exceeding 10 million users, specifically targeting the optimization of the carrier’s expanding 4G and 5G mobile infrastructure.
A syndicate of life sciences investors has poured $115 million into UK-based biotechnology firm RQ Bio to accelerate the clinical development of its lead antibody program. The funding aims to provide high-risk and immunocompromised patients with a single-dose treatment capable of delivering protection for an entire influenza season.
